A comparative study of gastric adenocarcinoma HER2 IHC phenotype and mass spectrometry-based quantification

INTRODUCTION: Gastric cancer is a highly heterogeneous malignant tumor of the digestive system. Anti-HER2 treatment can inhibit downstream signaling pathways and improve clinical treatment and outcomes in patients with HER2 protein overexpression. Currently, two standard methods for evaluating HER2...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bin, Chen, Hui, Zhang, Jingjing, Cong, Yanghai, Ning, Li, Chen, Limin, Zhang, Yushi, Zhang, Yong, Song, Zhanchun, Meng, Yuan, He, Lianqi, Liao, Wei-li, Lu, Ying, Zhao, Fengyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283037/
https://www.ncbi.nlm.nih.gov/pubmed/37350943
http://dx.doi.org/10.3389/fonc.2023.1152895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283037/
https://www.ncbi.nlm.nih.gov/pubmed/37350943
http://dx.doi.org/10.3389/fonc.2023.1152895

Ejemplares similares